The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Rhabdomyosarcoma, Alveolar

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Rhabdomyosarcoma, Alveolar


High impact information on Rhabdomyosarcoma, Alveolar


Chemical compound and disease context of Rhabdomyosarcoma, Alveolar


Biological context of Rhabdomyosarcoma, Alveolar


Anatomical context of Rhabdomyosarcoma, Alveolar


Gene context of Rhabdomyosarcoma, Alveolar


Analytical, diagnostic and therapeutic context of Rhabdomyosarcoma, Alveolar


  1. Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. van den Broeke, L.T., Pendleton, C.D., Mackall, C., Helman, L.J., Berzofsky, J.A. Cancer Res. (2006) [Pubmed]
  2. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Dias, P., Chen, B., Dilday, B., Palmer, H., Hosoi, H., Singh, S., Wu, C., Li, X., Thompson, J., Parham, D., Qualman, S., Houghton, P. Am. J. Pathol. (2000) [Pubmed]
  3. Antibodies to desmin identify the blastemal component of nephroblastoma. Folpe, A.L., Patterson, K., Gown, A.M. Mod. Pathol. (1997) [Pubmed]
  4. PAX3 gene structure, alternative splicing and evolution. Barber, T.D., Barber, M.C., Cloutier, T.E., Friedman, T.B. Gene (1999) [Pubmed]
  5. Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues. Khatua, S., Nair, C.N., Ghosh, K. J. Pediatr. Hematol. Oncol. (2004) [Pubmed]
  6. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Galili, N., Davis, R.J., Fredericks, W.J., Mukhopadhyay, S., Rauscher, F.J., Emanuel, B.S., Rovera, G., Barr, F.G. Nat. Genet. (1993) [Pubmed]
  7. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. Keller, C., Hansen, M.S., Coffin, C.M., Capecchi, M.R. Genes Dev. (2004) [Pubmed]
  8. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Keller, C., Arenkiel, B.R., Coffin, C.M., El-Bardeesy, N., DePinho, R.A., Capecchi, M.R. Genes Dev. (2004) [Pubmed]
  9. Metastatic alveolar rhabdomyosarcoma with increased serum creatine kinase MB and cardiac troponin T and normal cardiac troponin I. Isotalo, P.A., Greenway, D.C., Donnelly, J.G. Clin. Chem. (2000) [Pubmed]
  10. An evaluation of enzyme histochemistry in the diagnosis of childhood rhabdomyosarcoma. Variend, S., Loughlin, M.A. Histopathology (1985) [Pubmed]
  11. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response. Ruymann, F.B., Vietti, T., Gehan, E., Wiener, E., Wharam, M., Newton, W.A., Maurer, H. J. Pediatr. Hematol. Oncol. (1995) [Pubmed]
  12. Multiorgan uptake of Tc-99m MDP in a patient with stage 4 alveolar rhabdomyosarcoma. Freeman, S.J., Parker, A., Sandoval, C. Clinical nuclear medicine. (1998) [Pubmed]
  13. Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. Kindlmann, G.L., Weinstein, D.M., Jones, G.M., Johnson, C.R., Capecchi, M.R., Keller, C. Molecular imaging : official journal of the Society for Molecular Imaging. (2005) [Pubmed]
  14. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. Shapiro, D.N., Jones, B.G., Shapiro, L.H., Dias, P., Houghton, P.J. J. Clin. Invest. (1994) [Pubmed]
  15. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Fredericks, W.J., Ayyanathan, K., Herlyn, M., Friedman, J.R., Rauscher, F.J. Mol. Cell. Biol. (2000) [Pubmed]
  16. Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Ginsberg, J.P., Davis, R.J., Bennicelli, J.L., Nauta, L.E., Barr, F.G. Cancer Res. (1998) [Pubmed]
  17. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr, F.G. Oncogene (2001) [Pubmed]
  18. Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines. Chalk, J.G., Barr, F.G., Mitchell, C.D. Oncogene (1997) [Pubmed]
  19. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Khan, J., Bittner, M.L., Saal, L.H., Teichmann, U., Azorsa, D.O., Gooden, G.C., Pavan, W.J., Trent, J.M., Meltzer, P.S. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  20. Pax3 inhibits myogenic differentiation of cultured myoblast cells. Epstein, J.A., Lam, P., Jepeal, L., Maas, R.L., Shapiro, D.N. J. Biol. Chem. (1995) [Pubmed]
  21. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma. Rodeberg, D.A., Nuss, R.A., Heppelmann, C.J., Celis, E. Cancer Immunol. Immunother. (2005) [Pubmed]
  22. Immuno-histochemical localization of myoglobin in human muscle tissue and embryonal and alveolar rhabdomyosarcoma. Kindblom, L.G., Seidal, T., Karlsson, K. Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology. (1982) [Pubmed]
  23. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Bennicelli, J.L., Advani, S., Schäfer, B.W., Barr, F.G. Oncogene (1999) [Pubmed]
  24. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Ferracini, R., Olivero, M., Di Renzo, M.F., Martano, M., De Giovanni, C., Nanni, P., Basso, G., Scotlandi, K., Lollini, P.L., Comoglio, P.M. Oncogene (1996) [Pubmed]
  25. The role of Pax3 and Pax7 in development and cancer. Mansouri, A. Critical reviews in oncogenesis. (1998) [Pubmed]
  26. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Takahashi, Y., Oda, Y., Kawaguchi, K., Tamiya, S., Yamamoto, H., Suita, S., Tsuneyoshi, M. Mod. Pathol. (2004) [Pubmed]
  27. Molecular features in a biphenotypic small cell sarcoma with neuroectodermal and muscle differentiation. de Alava, E., Lozano, M.D., Sola, I., Panizo, A., Idoate, M.A., Martínez-Isla, C., Forteza, J., Sierrasesúmaga, L., Pardo-Mindán, F.J. Hum. Pathol. (1998) [Pubmed]
  28. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Davis, R.J., Bennicelli, J.L., Macina, R.A., Nycum, L.M., Biegel, J.A., Barr, F.G. Hum. Mol. Genet. (1995) [Pubmed]
  29. Resolved splenic accumulation of Tc-99m HMDP after recovery of disseminated intravascular coagulation in a patient with rhabdomyosarcoma. Suga, K., Matsunaga, N., Kawamura, T., Hara, A., Kume, N. Clinical nuclear medicine. (1999) [Pubmed]
WikiGenes - Universities